openPR Logo
Press release

Unfractionated Heparin Market Overview and Regional Outlook Study by 2025

03-01-2018 12:14 PM CET | Health & Medicine

Press release from: Transparency Market Research

Unfractionated Heparin Market Overview and Regional Outlook

The vendor landscape of the global Unfractionated Heparin Market features a largely consolidated nature, with several large international vendors and a handful of local players operating in the market, observes Transparency Market Research in a recent report. With the view of maintaining their strongholds on the market, leading companies are focusing acquiring or entering into strategic mergers and collaborations with promising small-scale vendors in lucrative regional markets. Investments in regional markets such as Latin America and Asia Pacific are increasing as companies look at exploiting growth opportunities in these regions with a large pool of untapped opportunities.

Some of the leading players operating in the global unfractionated heparin market are Pfizer, Inc., Baxter International Inc., Fresenius SE & Co. KGaA, LEO Pharma A/S, B. Braun Melsungen AG, and Sagent Pharmaceuticals.

According to the report, the global unfractionated heparin market was valued at US$955.9 mn in 2016 and is expected to expand at a CAGR of 6.4 % from 2017 to 2025, rising to an estimated value of US$1664.4 mn in 2025.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32198

Of the key sources of unfractionated heparin, the segment of porcine-based unfractionated heparin remained the key contributor towards the global market in 2016. Bovine sourced unfractionated heparin was banned in the U.S. and Europe region post 1990s due to the spread of bovine spongiform encephalopathy (BSE) disease in cattle. However, recently (2014) the Center for Drug Evaluation and Research (CDER) has proposed the re-introduction of bovine-based heparin due to shortage of porcine-based unfractionated heparin.

Geographically, the market for unfractionated heparin in North America accounted for the largest share in the global market in 2016, thanks to the rising prevalence of coagulation disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32198

Unfractionated heparin is a naturally occurring anticoagulant that finds primary usage in dialysis and as an anticoagulant for surgeries such as coronary artery bypass grafting. It is also used for the treatment of blood clotting disorders such as deep venous thrombosis and pulmonary embolism. The rapidly rise in prevalence of coagulation disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE) has led the increased global demand for unfractionated heparin in the past few years. While the precise number of people affected by these conditions is hard to find, several cohort studies estimate that DVT affects nearly 900,000 people each year in the U.S. alone.

The demand for unfractionated heparin is also fueled owing to factors such as its immediate onset of action, short half-life, simple laboratory monitoring, ability to get reversed (protamine), and low cost. While these factors are likely to continue to drive the market in the next few years as well, the market will also benefit from the increased demand from regions such as Asia Pacific and Europe wherein the population of geriatrics is rising rapidly. Across the globe, the vast rise in cardiovascular surgeries requiring unfractionated heparin as the preferred anticoagulant is also expected to work in favor of the market.

View Report -

https://www.transparencymarketresearch.com/unfractionated-heparin-drug-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Unfractionated Heparin Market Overview and Regional Outlook Study by 2025 here

News-ID: 962501 • Views: 190

More Releases from Transparency Market Research

Offshore Hydropower Market - Development and Growth Forecast by Regions and Appl …
Global Offshore Hydropower Market: Overview The global offshore hydropower market is substantially gaining from the rising demand for clean energy. Concerns pertaining to the depleting resource of fossil-based fuels and the increasing carbon footprint are fuelling demand for renewable energy, subsequently boosting the global offshore hydropower market. Offshore hydropower plants can be classified based on their production capacity into large, small, micro, and Pico-hydro power plants. Plants exhibiting a production capacity of
Back End of the Line Semiconductor Equipment Market To 2024 Market Comparison By …
Back End of Line Semi-Conductor Equipment is the second part of semiconductor devices where single devices such as capacitors, transistors and resistors, among others are interconnected by wires on wafer which are made by pure silicon and metal layers to form required electrical circuits. Common metal that forms layers are aluminum interconnect and copper interconnect. Back end of the line in semiconductor equipments is started when the wafer gets deposited
Wireless Intercom Market To 2023 Growth Analysis By Manufacturers, Regions, Fore …
The intense competition between RTS Intercom, Clear-Com Ltd., and Commend International GmbH characterizes the competitive landscape of the market for wireless intercom in Asia Pacific, finds a report by Transparency Market Research. These wireless intercom manufacturers rely on product innovations and integration of latest technologies in their existing offerings to grab an edge over each other. For instance, Commend Int. introduced an advanced version of its intercom solution in April 2015,
3D Time-of-Flight Image Sensor Market To 2025 Report, Trends, Size, Share, Analy …
3D time of flight tools, products and development kits facilitates the next generation of the machine vision with the actual 3D imaging depth camera. Starting from the robotic navigation to the building automation and gesture recognition, 3D time of flight chipsets does allow maximum flexibility to customize every facet of the camera's design. The growth of 3d time-of-flight image sensor market is highly reliant on the growth of overall

All 5 Releases


More Releases for Unfractionated

Unfractionated Heparin Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-other-reports/unfractionated-heparin-market/71819 The global market size of Unfractionated Heparin is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,
Unfractionated Heparin Market to Record Sturdy Growth by 2025
The largely consolidated vendor landscape of the global Unfractionated Heparin Market features several large international companies and a handful of well-established local players operating in promising regional markets, states Transparency Market Research in a recent report. To gain a larger control on the market, companies are putting more emphasis on strategic collaborations and expansion in lucrative untapped regional markets. Focus on regional markets such as Asia Pacific and Latin America
Unfractionated Heparin Market Outlook, and Opportunity Analysis, 2018-2026
Unfractionated heparin (UFH) is a natural agent widely used to prevent clot formation in vessels. Unfractionated heparin is a fast-acting blood thinner, which works with antithrombin, a natural protein in the body, to block clot formation. UFH is administered to patient intravenously into an arm vein or as a subcutaneous injection under the skin. UFH can also be administrated orally. However, oral absorption of unfractionated heparin is poor, owing to
Unfractionated Heparin Market Projected to be Resilient During 2025
Global Unfractionated Heparin Market: Overview This report on unfractionated heparin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing unfractionated heparin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments
Global Unfractionated Heparin Market Assessment & Development Forecast during 20 …
Unfractionated heparin is known as a naturally occurring anticoagulant which is primarily in dialysis as well as heart lung machines for the prevention of blood clots. In order to study the market for unfractionated heparin, Market Research Hub (MRH) has included a new research report titled “Unfractionated Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017- 2025”, to its wide database. This assessment studies the present
Global Unfractionated Heparin Market Insights: Premium Market Research Report 20 …
Reports Monitor publishes Global Unfractionated Heparin Market Report 2017-2022 to its database This report is split area wise globally and has included many important regions. The sales, revenue, market share and Growth rate of Unfractionated Heparin Marketof these regions from 2017 to 2022 (forecast) are North America Europe China Japan Southeast Asia India Request a Sample Copy of this Report @ https://www.reportsmonitor.com/request-sample/?post=450712  The top competitors for Unfractionated Heparin Marketaccording to the sales volume, Price, (K USD /Unit), Revenue (Million USD),